Newspaper Publication of Q2 FY 2019-20
Latest Announcements
Glenmark’s consolidated revenue rises 9.05% to Rs. 28,150.4 Mn. in Q2 FY 2019-20
14 Nov 2019 | Read More
Glenmark’s MDA Q2 FY 2019 – 20
14 Nov 2019 | Read More
Glenmark’s Q2 FY 2019-20 Results
14 Nov 2019 | Read More
Glenmark Pharmaceuticals receives ANDA approval for Adapalene and Benzoyl Peroxide Gel, 0.1%|2.5%
11 Nov 2019 | Read More
Q2 FY20 Earnings Concall Invitation - November 15, 2019
7 Nov 2019 | Read More
BM Notice Newspaper Publication – 14th November, 2019
6 Nov 2019 | Read More
Notice of Board Meeting - 14th November, 2019
5 Nov 2019 | Read More
Proceedings and Scrutinizer's Report of the 41st AGM
28 Sep 2020 | Read More
Newspaper Publication of Annual General Meeting Notice
5 Sep 2019 | Read More
Glenmark AGM Notice 2019
3 Sep 2019 | Read More
AGM Intimation to the Exchange
25 Aug 2019 | Read More
Glenmark Pharmaceuticals receives ANDA approval for Fulvestrant Injection, 250 mg/5 mL (50 mg/mL)
23 Aug 2019 | Read More
Glenmark’s consolidated revenue at Rs. 23,228.79 Mn. for Q1 FY 2019 – 20
13 Aug 2019 | Read More
Glenmark’s MDA Q1 FY 2019 – 20
13 Aug 2019 | Read More
Glenmark’s Q1 FY 2019-20 Results
13 Aug 2019 | Read More
Glenmark Q1 FY 2019 – 20 Results Earnings Call
5 Aug 2019 | Read More
BM Notice Newspaper Publication – 13th August, 2019
1 Aug 2019 | Read More
Notice of Board Meeting - 13th August, 2019
31 Jul 2019 | Read More
Credit Rating by Fitch Ratings
11 Jul 2019 | Read More
Newspaper Publication - Notice to Shareholder for transfer of shares to IEPF
26 Jun 2019 | Read More
FDA Issues Complete Response Letter for Ryaltris™ (olopatadine hydrochloride [665 mcg] and mometasone furoate [25 mcg])
22 Jun 2019 | Read More
Newspaper Publication of Q4 Results
31 May 2019 | Read More
Glenmark’s consolidated revenue rises 12.44% to Rs. 25,634.74 Mn. for Q4 FY 2018-19
29 May 2019 | Read More
Glenmark’s MDA Q4 FY 2018 – 19
29 May 2019 | Read More
Glenmark’s Q4 FY 2018-19 Results
29 May 2019 | Read More
BM Notice Newspaper Publication – 29th May, 2019
22 May 2019 | Read More
Glenmark Q4 FY 2018 - 19 Results Earnings Call
21 May 2019 | Read More
Board Meeting Intimation – 29th May, 2019
14 May 2019 | Read More
Newspaper Publication of Q3 Results
18 Feb 2019 | Read More
Glenmark’s consolidated revenue rises 15.95% to Rs. 25,550.45 Mn. in Q3 FY 2018 – 19
14 Feb 2019 | Read More
Glenmark’s MDA Q3 FY 2018 – 19
14 Feb 2019 | Read More
Glenmark’s Q3 FY 2018-19 Results
14 Feb 2019 | Read More
BM Newspaper Publication – 14th February, 2019
4 Feb 2019 | Read More
Glenmark Q3 FY 2018 - 19 Results Earnings Call
4 Feb 2019 | Read More
Board Meeting Intimation – 14th February, 2019
1 Feb 2019 | Read More
J P Morgan Healthcare Conference 2019 I Presentation
8 Jan 2019 | Read More
Newspaper Publication of Q2 Results
23 Nov 2018 | Read More
Glenmark’s consolidated revenue rises 14.39% to Rs. 25,813.32 Mn. in Q2 FY 2018 – 19
13 Nov 2018 | Read More
Glenmark’s MDA Q2 FY 2018 – 19
13 Nov 2018 | Read More
Glenmark’s Q2 FY 2018-19 Results
13 Nov 2018 | Read More
BM Newspaper Publication
5 Nov 2018 | Read More
Board Meeting Notice November 13, 2018
2 Nov 2018 | Read More
Announcement of Results of the Repurchase
3 Oct 2018 | Read More
Newspaper Publication of Annual General Meeting Notice
28 Sep 2018 | Read More
AGM Intimation to the exchange
21 Aug 2018 | Read More
Newspaper Publication of Q1 Results
19 Aug 2018 | Read More
Glenmark’s consolidated revenue at Rs. 21,656.17 Mn. for Q1 FY 2018 – 19
10 Aug 2018 | Read More
Glenmark’s Q1 FY 2018-19 Results
10 Aug 2018 | Read More
Glenmark’s MDA Q1 FY 2018 – 19
10 Aug 2018 | Read More
Q1 FY19 Earnings Concall Invitation - Aug 13, 2018
3 Aug 2018 | Read More
Glenmark BM Notice Navshakti
31 Jul 2018 | Read More
Glenmark BM Notice FPJ
31 Jul 2018 | Read More
IEPF – Notice to Shareholders
29 Jun 2018 | Read More
Newspaper Publication of Q4/Annual Results - Loksatta
6 Jun 2018 | Read More
Newspaper Publication of Q4/Annual Results
5 Jun 2018 | Read More
Glenmark’s consolidated revenue at Rs. 22,798.16 Mn. for Q4 FY 2017 – 18
29 May 2018 | Read More
Glenmark’s MDA Q4 FY 18
29 May 2018 | Read More
Glenmark’s Q4 FY18 Results
29 May 2018 | Read More
Q4 Earnings Concall Invitation
28 May 2018 | Read More
Glenmark BM Notice Navshakti
17 May 2018 | Read More
Glenmark BM Notice FPJ
17 May 2018 | Read More
Newspaper Publication of Q3 Results
9 Feb 2018 | Read More
AGM Notice Announcement
8 Sep 2017 | Read More
Board Meeting Notice July 27, 2017
14 Jul 2017 | Read More
Glenmark FPJ Page 10
14 Jul 2017 | Read More
Glenmark Navshakti Page 8
14 Jul 2017 | Read More
Glenmark Pharmaceuticals Receives Tentative ANDA Approval For Solifenacin Succinate Tablets, 5 mg and 10 mg
22 Jun 2017 | Read More
Glenmark's consolidated revenue increased by 6.52% to Rs. 24,571.83 Mn for Q4 FY 2016 -- 17
11 May 2017 | Read More
Q4 FY 2017 Results sheet & Statement of Assets and Liabilities
11 May 2017 | Read More
Q4 FY 2017 Management Discussions and Analysis
11 May 2017 | Read More
Q4 Earnings Concall Invitation May 12, 2017
8 May 2017 | Read More
The Free Press Journal
5 May 2017 | Read More
Navshakti
5 May 2017 | Read More
Intimation regarding NSE board meeting
3 May 2017 | Read More
Statement on Form 483 at the Ankleshwar API plant
20 Feb 2017 | Read More
Glenmark’s Q3 FY 17 results
2 Feb 2017 | Read More
Glenmark’s MDA Q3 FY 17
2 Feb 2017 | Read More
Glenmark’s consolidated revenue increases by 42.55 % to Rs. 25,350.08 Mn for Q3 FY 2016 – 17
2 Feb 2017 | Read More
J P Morgan Healthcare Conference – presentation
30 Jan 2017 | Read More
Intimation regarding board meeting
17 Jan 2017 | Read More
Statement of Investor Complaints for Q3 (F. Y. 2016-17)
11 Jan 2016 | Read More
Webcast of analyst and investor meet 2016
29 Dec 2016 | Read More
Strategic Blueprint for the Next Decade – Investor presentation
19 Dec 2016 | Read More
Strategic Blueprint for the Next Decade – Media presentation
19 Dec 2016 | Read More
Glenmark's Q2 FY17 Result Balance Sheet
2 Nov 2016 | Read More
Glenmark's MDA Q2 FY 2017
2 Nov 2016 | Read More
Glenmark’s consolidated revenue increases by 16.48% to Rs. 22241.09 Mn for Q2 FY 2016 – 17
2 Nov 2016 | Read More
Reconciliation of Share Capital Audit Report
10 Oct 2016 | Read More
Compliance Certificate under Regulation 7(3)
10 Oct 2016 | Read More
Certificate from Practicing Company Secretary under Regulation 40(9)
10 Oct 2016 | Read More
Statement of Investor Complaints for Q2
10 Oct 2016 | Read More
Shareholding Pattern for Q2
10 Oct 2016 | Read More
Corporate Governance Report for Q2
10 Oct 2016 | Read More
38th AGM Proceedings
12 Aug 2016 | Read More
38th AGM Notice – The Free Press Journal
21 Jul 2016 | Read More
38th AGM Notice – Navshakti
21 Jul 2016 | Read More
Glenmark e-voting notice
19 Jul 2016 | Read More
Glenmark notice proxy form
19 Jul 2016 | Read More
Annual report FY 2016
19 Jul 2016 | Read More
Intimation to the exchange
18 Jul 2016 | Read More
Statement of Investor Complaint
13 Jul 2016 | Read More
Reconciliation Share Capital
30 Jun 2016 | Read More
Q4 Shareholding Pattern
30 Jun 2016 | Read More
Corporate governance website
30 Jun 2016 | Read More
Approval of Subscription Agreement for FCCB's
31 May 2016 | Read More
Launch of FCCB's
31 May 2016 | Read More
Q4 - Statement of Investor Complaints
7 Apr 2016 | Read More
Q4 - Reconciliation Share Capital
31 Mar 2016 | Read More
Q4 - Format of Holding of specified securities (2)
31 Mar 2016 | Read More
Q4 - Format of Holding of specified securities
31 Mar 2016 | Read More
Cancellations of ESOP Options
28 Jan 2016 | Read More
Authorised KMP for Disclosure of Materality of Events or Information
28 Jan 2016 | Read More
Glenmark JPMorgan 2016
15 Jan 2016 | Read More

About Us
Leading, integrated, global, research-led organization. Words which define us and our vision to discover a healthier futureContact Us
For shareholder queries, please email to
complianceofficer@glenmarkpharma.com